DiscoverThe Lancet in conversation withPresented at ASCO: the first RCT of CAR T-cell therapy in solid tumours
Presented at ASCO: the first RCT of CAR T-cell therapy in solid tumours

Presented at ASCO: the first RCT of CAR T-cell therapy in solid tumours

Update: 2025-05-31
Share

Description

Changsong Qi joins Chloe Wilson and Ben Abbott of The Lancet to discuss their recently published phase 2 randomised controlled trial investigating Claudin-18 isoform 2-specific CAR T-cell therapy for previously treated advanced gastric or gastro-oesophageal junction cancer.

Read the full article:

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00860-8/fulltext?dgcid=buzzsprout_icw_podcast_May_25_lancet

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
In Channel
ASCO 2025 Debrief

ASCO 2025 Debrief

2025-06-1115:14

Previewing ASCO 2025

Previewing ASCO 2025

2025-05-3005:24

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Presented at ASCO: the first RCT of CAR T-cell therapy in solid tumours

Presented at ASCO: the first RCT of CAR T-cell therapy in solid tumours

The Lancet Group